Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C N Coupling. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111592487B reveals potent dual-target anticancer agents. Efficient synthesis offers cost reduction in pharmaceutical intermediate manufacturing.
Patent CN104961706B details efficient ML345 synthesis reducing steps and cost for pharmaceutical intermediates manufacturing supply chain reliability and high purity standards globally.
Patent CN111574538A reveals a metal-free D-A type near-infrared organic luminescent material offering cost reduction in electronic chemical manufacturing and scalable production.
Patent CN114957240B reveals narrow-spectrum fluorescent compounds enhancing OLED color purity and manufacturing efficiency for global display supply chains and electronic material procurement.
Novel 8-step route for Bortezomib using isobutylboronic acid, eliminating column chromatography for cost-effective manufacturing.
Novel Pictet-Spengler and Heck coupling strategy enables scalable production of anti-inflammatory alkaloid Arbornamine with improved cost efficiency.
Patent CN115385909A details a novel Pd/Cu method for imidazophenanthridines, offering mild conditions and high purity for pharmaceutical intermediates.
Patent CN116284010A reveals a novel 3-step route to FPTX energetic materials, offering enhanced safety and scalability for high-energy density compound manufacturing.
Patent CN106983872A reveals a novel DHA-docetaxel conjugate synthesis improving solubility and reducing toxicity for scalable pharmaceutical intermediate manufacturing supply chains.
Patent CN102372729A details a novel, high-yield synthesis of Cefoperazone Sodium using recyclable dimethyl carbonate, offering significant cost and purity advantages for pharmaceutical manufacturers.
Patent CN110396051A reveals novel hole transport materials with high thermal stability. Enables cost reduction in electronic chemical manufacturing and reliable supply chains.
Patent CN107298684A reveals efficient intramolecular cyclization. Offers cost reduction in pharmaceutical intermediate manufacturing and high-purity spiroindolinones.
Patent CN100588643C details a scalable synthesis for novel disubstituted adamantyl retinoic acids. Offers high purity, simplified processing, and cost-effective API manufacturing solutions.
Patent CN114525529B reveals a green electrochemical route for thio(seleno)phosphoric acid thioesters, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN111807986B details a novel copper-catalyzed C-N coupling using oxalohydrazide ligands. Discover cost-effective synthesis routes for aryl hydrazines suitable for industrial scale-up.
Patent CN113999166B details a novel Negishi coupling route for Tenibulin, offering milder conditions and higher yields for cost-effective API manufacturing.
Patent CN114516779A details site-selective bromination and borylation of DHR, enabling cost reduction in electronic chemical manufacturing and scalable OLED intermediate production.
Novel copper-catalyzed route offers high yield and green chemistry advantages for pharmaceutical and OLED material supply chains globally.
Novel 1-aza-5-germanocarbobicyclo[3.3.3]undecane synthesis via patent CN112194674B. Stable air-tolerant intermediates for advanced material manufacturing.
Patent CN117263941B reveals a novel EGFR inhibitor synthesis with high purity and atom economy. Discover cost reduction and supply chain advantages for pharmaceutical manufacturing.